Sequent Scientific Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 387.4790 crores during the period ended March 31, 2022 as compared to Rs. 361.7150 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 8.9620 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 17.1160 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 0.36 for the period ended March 31, 2022 as compared to Rs. 0.68 for the period ended December 31, 2021.
Total Income | ₹ 387.4790 crs | ₹361.7150 crs | 7.12% |
Net Profit | ₹8.9620 crs | ₹17.1160 crs | -47.64% |
EPS | ₹0.36 | ₹0.68 | -47.06% |
Financial Results (Q4 FY2022) - YoY Comparison The company has reported total income of Rs. 387.4790 crores during the period ended March 31, 2022 as compared to Rs.363.1957 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.8.9620 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.20.6329 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.36 for the period ended March 31, 2022 as compared to Rs.0.84 for the period ended March 31, 2021.
Total Income | ₹ 387.4790 crs | ₹363.1957 crs | 6.69% |
Net Profit | ₹8.9620 crs | ₹20.6329 crs | -56.56% |
EPS | ₹0.36 | ₹0.84 | -57.14% |
Financial Results (Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.1423.6610 crores during the Financial Year ended March 31, 2022 as compared to Rs.1369.9780 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.41.2510 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.95.4420 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.1.65 for the Financial Year ended March 31, 2022 as compared to Rs.3.85 for the Financial Year ended March 31, 2021.
Total Income | ₹1423.6610 crs | ₹1369.9780 crs | 3.92% |
Net Profit | ₹41.2510 crs | ₹95.4420 crs | -56.78% |
EPS | ₹1.65 | ₹3.85 | -57.14% |
Shares of Sequent Scientific Limited was last trading in BSE at Rs. 121.85 as compared to the previous close of Rs. 125.60. The total number of shares traded during the day was 250775 in over 4292 trades.
The stock hit an intraday high of Rs. 133.10 and intraday low of 120.25. The net turnover during the day was Rs. 31696748.00.
Source : Equity Bulls
Keywords
SequentScientific
Q4FY22
FY2022
ResultUpdate